MDC1 counteracts restrained replication fork restart and its loss causes chemoresistance in BRCA1/2-deficient mammary tumors
Martin LiptayiD, Joana S. Barbosa, Ewa GogolaiD, Alexandra A. Duarte, Diego DibitettoiD, Jonas Andreas SchmidiD, Ismar Klebic, Merve MutluiD, Myriam Siffert, Paola FrancicaiD, Israel SalgueroiD, Marieke van de VeniD, Renske de Korte‐Grimmerink, Stephen P. JacksoniD, Jos JonkersiD, Massimo LopesiD, Sven RottenbergiD
Abstract
MDC1 is a key protein in DNA damage signaling. When DNA double-strand breaks (DSBs) occur, MDC1 localizes to sites of damage to promote the recruitment of other factors, including the 53BP1-mediated DSB repair pathway. By studying mechanisms of poly(ADP-ribose) polymerase inhibitor (PARPi) resistance in BRCA2;p53-deficient mouse mammary tumors, we identified a thus far unknown role of MDC1 in replication fork biology. MDC1 localizes at active replication forks during normal fork replication and its loss reduces fork speed. We show that MDC1 contributes to the restart of replication forks and thereby promotes sensitivity to PARPi and cisplatin. Loss of MDC1 causes MRE11-mediated resection, resulting in delayed fork restart. This improves DNA damage tolerance and causes chemoresistance in BRCA1/2-deficient cells. Hence, our results show a role for MDC1 in replication fork progression that mediates PARPi- and cisplatin-induced DNA damage, in addition to its role in DSB repair.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 6
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumors
J. Bhin, M. Paes Dias, … J. Jonkers·bioRxiv·Sep 7, 2022
- STN1 upregulation promotes PARPi resistance in BRCA2-deficient cancer cells via replication fork protection and suppression of ssDNA gap formation
Zubair Ahmed Laghari, Na Li, … Weihang Chai·NAR CancerPeer-reviewed·Jul 27, 2026
- Phosphorylation Status Of MUS81 Is A Modifier Of Olaparib Sensitivity In BRCA2-Deficient Cells
F. Blandino, E. Malacaria, … P. Pichierri·bioRxiv·Aug 13, 2022
- Replication poison treated BRCA1-deficient breast cancers are prone to MRE11 over-resection resulting in single strand DNA accumulation and mitotic catastrophe
I. Tabet, E. Orhan, … C. Theillet·bioRxiv·Oct 31, 2023
- Replication Fork-Associated Checkpoint Mediator Mrc1/Claspin Acts in Arrest-Independent Double-Strand Break Survival
Marissa Ashton, Elliot Busch, James E. Haber·bioRxiv·Sep 17, 2026
- FANCJ promotes PARP1 activity during DNA replication that is essential in BRCA1 deficient cells
Ke Cong, Nathan J. MacGilvary, … Sharon B. Cantor·Nature CommunicationsPeer-reviewed·Mar 23, 2024